Haoxi Health Technology Limited Class A Ordinary Shares (HAO) - Net Assets
Based on the latest financial reports, Haoxi Health Technology Limited Class A Ordinary Shares (HAO) has net assets worth $17.38 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($21.60 Million) and total liabilities ($4.22 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check HAO asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $17.38 Million |
| % of Total Assets | 80.46% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 280.17 |
Haoxi Health Technology Limited Class A Ordinary Shares - Net Assets Trend (2020–2025)
This chart illustrates how Haoxi Health Technology Limited Class A Ordinary Shares's net assets have evolved over time, based on quarterly financial data. Also explore how large is Haoxi Health Technology Limited Class A 's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for Haoxi Health Technology Limited Class A Ordinary Shares (2020–2025)
The table below shows the annual net assets of Haoxi Health Technology Limited Class A Ordinary Shares from 2020 to 2025. For live valuation and market cap data, see Haoxi Health Technology Limited Class A stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $17.38 Million | +54.16% |
| 2024-12-31 | $11.27 Million | 0.00% |
| 2023-12-31 | $11.27 Million | +619.56% |
| 2022-12-31 | $1.57 Million | +206.88% |
| 2021-12-31 | $-1.47 Million | +24.10% |
| 2020-12-31 | $-1.93 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Haoxi Health Technology Limited Class A Ordinary Shares's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 638268600.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $4.60 Million | 26.47% |
| Common Stock | $7.24K | 0.04% |
| Other Comprehensive Income | $-45.52K | -0.26% |
| Other Components | $12.81 Million | 73.75% |
| Total Equity | $17.38 Million | 100.00% |
Haoxi Health Technology Limited Class A Ordinary Shares Competitors by Market Cap
The table below lists competitors of Haoxi Health Technology Limited Class A Ordinary Shares ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kocom Co. Ltd
KQ:015710
|
$43.47 Million |
|
LTKM Bhd
KLSE:7085
|
$43.48 Million |
|
Rallybio Corp
NASDAQ:RLYB
|
$43.48 Million |
|
Sheetal Cool Products Limited
NSE:SCPL
|
$43.49 Million |
|
Minehub Technologies Inc
V:MHUB
|
$43.47 Million |
|
Prestige Wealth Inc.
NASDAQ:AURE
|
$43.47 Million |
|
Crest Group Berhad
KLSE:0323
|
$43.46 Million |
|
Cyan AG
XETRA:CYR
|
$43.46 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Haoxi Health Technology Limited Class A Ordinary Shares's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 11,271,955 to 17,376,430, a change of 6,104,475 (54.2%).
- Net income of 3,876,680 contributed positively to equity growth.
- Other comprehensive income decreased equity by 1,133.
- Other factors increased equity by 2,228,928.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $3.88 Million | +22.31% |
| Other Comprehensive Income | $-1.13K | -0.01% |
| Other Changes | $2.23 Million | +12.83% |
| Total Change | $- | 54.16% |
Book Value vs Market Value Analysis
This analysis compares Haoxi Health Technology Limited Class A Ordinary Shares's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.10x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $-0.19 | $0.74 | x |
| 2021-12-31 | $-0.15 | $0.74 | x |
| 2022-12-31 | $0.14 | $0.74 | x |
| 2023-12-31 | $0.38 | $0.74 | x |
| 2024-12-31 | $0.92 | $0.74 | x |
| 2025-12-31 | $7.25 | $0.74 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Haoxi Health Technology Limited Class A Ordinary Shares utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 22.31%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.82%
- • Asset Turnover: 1.52x
- • Equity Multiplier: 1.24x
- Recent ROE (22.31%) is above the historical average (17.85%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.00% | 2.37% | 4.57x | 0.00x | $497.17K |
| 2021 | 0.00% | 1.51% | 29.76x | 0.00x | $391.16K |
| 2022 | 61.91% | 3.44% | 6.32x | 2.85x | $813.10K |
| 2023 | 11.44% | 2.66% | 3.13x | 1.38x | $162.80K |
| 2024 | 11.46% | 2.66% | 3.13x | 1.38x | $164.47K |
| 2025 | 22.31% | 11.82% | 1.52x | 1.24x | $2.14 Million |
Industry Comparison
This section compares Haoxi Health Technology Limited Class A Ordinary Shares's net assets metrics with peer companies in the Advertising Agencies industry.
Industry Context
- Industry: Advertising Agencies
- Average net assets among peers: $150,062,749
- Average return on equity (ROE) among peers: -10.04%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Haoxi Health Technology Limited Class A Ordinary Shares (HAO) | $17.38 Million | 0.00% | 0.24x | $43.47 Million |
| ACCESS Newswire Inc. (ACCS) | $35.42 Million | 2.16% | 0.84x | $31.53 Million |
| Advantage Solutions Inc (ADV) | $1.10 Billion | -5.74% | 2.42x | $202.97 Million |
| Advantage Solutions Inc (ADVWW) | $1.74 Billion | 1.85% | 2.42x | $46.28 |
| Airnet Technology Inc (ANTE) | $123.68 Million | -72.85% | 0.82x | $385.29 Million |
| Applovin Corp (APP) | $1.26 Billion | 28.39% | 3.27x | $128.13 Billion |
| Baosheng Media Group Holdings Ltd (BAOS) | $74.06 Million | -9.11% | 0.27x | $4.04 Million |
| Clear Channel Outdoor Holdings Inc (CCO) | $-3.26 Billion | 0.00% | 0.00x | $1.18 Billion |
| Cardlytics Inc (CDLX) | $143.27 Million | -11.97% | 0.57x | $47.92 Million |
| Cheer Holding Inc. (CHR) | $252.39 Million | 5.11% | 0.00x | $5.39 Million |
| ZW Data Action Technologies Inc (CNET) | $35.91 Million | -38.26% | 0.32x | $2.37 Million |
About Haoxi Health Technology Limited Class A Ordinary Shares
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various … Read more